Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-15
    E.g., 2018-10-15

Archive Search

3 results
12:00 AM, Mar 12, 2012  |  BioCentury | Product Development

Replacing the replacements

including JR-032 , a recombinant iduronate-2 sulfatase to treat MPS II; JR-051 , a recombinant alpha galactosidase
an enzyme replacement therapy but rather is a small molecule that enhances the activity of alpha galactosidase
12:00 AM, Oct 27, 2003  |  BioCentury | Product Development

The pharming field

lymphoma (NHL) Completed Ph I Progress to Ph III; on hold due to financing Recombinant alpha- galactosidase
12:00 AM, Sep 23, 2002  |  BioCentury | Product Development

Bitter rivalry

Disorders. The products treat patients who have an inherited disorder that prevents them from producing alpha-galactosidase